Performance Impairment and its Association to other
Alterations in Cannabis users
Authors:
Diogo FBC, Anne Orgler DS, Felipe O, Lisia von D, Juliana NSD, Nino M, Renata PLD*, Felix HPK
Author Affiliations
Diogo FBC Psychiatrist specialized in addiction. Curitiba, Paraná, Brasil
Anne Orgler DS Psychiatrist and PhD of Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil
Felipe O Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, RS, Brazil; Postgraduate Program in Psychiatry and Behavioral Science, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil
Lisia von D Psychiatrist and Professor Department of Psychiatry and Legal Medicine. Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas of Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil
Juliana NSD Biomedical Specialist and PhD in Psychiatry of Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil
Nino M Psychologist and Master in Science of Pharmaceutical and Toxicologist by University Federal of Rio Grande do Sul, Porto Alegre, Brazil.Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil
Renata PLD* Pharmaceutical and Toxicologist. Professor of Clinical analysis Departament in the Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil Email:
renata.limberger@ufrgs.br
Felix HPK Psychiatrist and Professor Department of Psychiatry and Legal Medicine in University Federal of Rio Grande do Sul, Porto Alegre, Brazil
Cannabis is the most frequently used drug worldwide. Its use is often associated to socioeconomic, academic and professional impairment. Although there are several damages resulting from its consumption, there are currently no studies which broadly explore why these performance impairments happen. This study is a narrative review, based on articles selected from Embase, Medline, PsycInfo and Web of Science databases. This study aims at exploring the performance deficits associated with Cannabis use, as well as the possible cognitive-behavioral, emotional and motivational alterations which may explain them. Chronic Cannabis use leads to central nervous system changes, involving the endocannabinoid system (cerebral reward and cortical functioning system), resulting in deficits i several cognitive, behavioral, emotional and motivational domains. There is significant impairment in learning, attention, memory, decision making and inhibitory control, as well as an increase in depressive, anxious and dysphoric symptoms. These symptoms may be associated to poor academic performance, reducing chances of obtaining a degree, higher levels of study evasion, unemployment and work absence, lower salaries and higher need of financial aid. These results suggest that performance impairments related to chronic Cannabis use may be due to biopsychosocial factors, which are interrelated and contribute to losses in several domains of the users lives.
Keywords
Cannabis; Academic Performance; Professional Performance; Cognition; Motivation